GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Momentum Rank

MediPharm Labs (TSX:LABS) Momentum Rank : 0 (As of Apr. 14, 2025)


View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Momentum Rank?

MediPharm Labs has the Momentum Rank of 0.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

MediPharm Labs Momentum Rank Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Momentum Rank
Comparable Companies
XCNQ:VEXT TSXV:LSL TSXV:DB TSX:AVCN XCNQ:LEEF XCNQ:IAN NEOE:CBST TSXV:ROMJ XCNQ:FNT.U XCNQ:CXXI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
MEDIF:USA MLZ:Germany
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
Website
https://www.medipharmlabs.com
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Executives
Keith Strachan Director
Gregory Edison Hunter Senior Officer
David Pidduck Director, Senior Officer
Bryan Howcroft Director, Senior Officer
Patrick Mccutcheon Director
Warren Everitt Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust 10% Security Holder
Christopher David Taves Director
Sybil Taylor Senior Officer
Braden Fenske Senior Officer
David John Mayers Senior Officer

MediPharm Labs Headlines